Arbutus Biopharma
comparable mean declines were observed in all cohorts | Arbutus Biopharma
Company
Deck Type
Sector
Industry
Deck date
January 2024
Slide
11 of 26
Related slides by other companies
Aeglea BioTherapeutics
Investor Presentation
May 2023
improvements in mobility measures sustained over time in phase and stam some mean change from ase | Aeglea BioTherapeutics
Aeglea BioTherapeutics
Investor Presentation
April 2023
improvements in mobility measures sustained over time in phase and stam some mean change from ase | Aeglea BioTherapeutics
Tudor, Pickering, Holt & Co
Investment Banking
October 2018
am selected comparable company analysis | Tudor, Pickering, Holt & Co
Aeglea BioTherapeutics
Investor Presentation
March 2023
improvements in mobility measures sustained over time in phase and a mean change from aes | Aeglea BioTherapeutics
Other recent decks by Arbutus Biopharma
See all presentations (8 decks)
Investor Presentation
June 2024
Investor Presentation
November 2023
Investor Presentation
October 2023
Investor Presentation
August 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io